Skip to main content

Mutations associated with hypokalemic periodic paralysis: from hotspot regions to complete analysis of CACNA1S and SCN4A genes

Abstract

Familial periodic paralyses (PPs) are inherited disorders of skeletal muscle characterized by recurrent episodes of flaccid muscle weakness. PPs are classified as hypokalemic (HypoPP), normokalemic (NormoPP), or hyperkalemic (HyperPP) according to the potassium level during the paralytic attacks. HypoPP is an autosomal dominant disease caused by mutations in the CACNA1S gene, encoding for Cav1.1 channel (HypoPP-1), or SCN4A gene, encoding for Nav1.4 channel (HypoPP-2). In the present study, we included 60 patients with a clinical diagnosis of HypoPP. Fifty-one (85%) patients were tested using the direct sequencing (Sanger method) of all reported HypoPP mutations in CACNA1S and SCN4A genes; the remaining 9 (15%) patients were analyzed through a next-generation sequencing (NGS) panel, including the whole CACNA1S and SCN4A genes, plus other genes rarely associated to PPs. Fifty patients resulted mutated: 38 (76%) cases showed p.R528H and p.R1239G/H CACNA1S mutations and 12 (24%) displayed p.R669H, p.R672C/H, p.R1132G/Q, and p.R1135H SCN4A mutations. Forty-one mutated cases were identified among the 51 patients managed with Sanger sequencing, while all the 9 cases directly analyzed with the NGS panel showed mutations in the hotspot regions of SCN4A and CACNA1S. Ten out of the 51 patients unresolved through the Sanger sequencing were further analyzed with the NGS panel, without the detection of any mutation. Hence, our data suggest that in HypoPP patients, the extension of genetic analysis from the hotspot regions using the Sanger method to the NGS sequencing of the entire CACNA1S and SCN4A genes does not lead to the identification of new pathological mutations.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2

References

  1. 1.

    Suetterlin K, Männikkö R, Hanna MG (2014) Muscle channelopathies: recent advances in genetics, pathophysiology and therapy. Curr Opin Neurol 27:583–590. https://doi.org/10.1097/WCO.0000000000000127

    CAS  Article  PubMed  Google Scholar 

  2. 2.

    Maggi L, Bonanno S, Altamura C, Desaphy J-F (2021) Ion channel gene mutations causing skeletal muscle disorders: pathomechanisms and opportunities for therapy. Cells 10:1521. https://doi.org/10.3390/cells10061521

    Article  PubMed  PubMed Central  Google Scholar 

  3. 3.

    Statland JM, Fontaine B, Hanna MG, Johnson NE, Kissel JT, Sansone VA et al (2018) Review of the diagnosis and treatment of periodic paralysis. Muscle Nerve 57:522–530. https://doi.org/10.1002/mus.26009

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    Ke Q, Luo B, Qi M, Yue Du, Weiping Wu (2013) Gender differences in penetrance and phenotype in hypokalemic periodic paralysis. Muscle Nerve 47:41–45. https://doi.org/10.1002/mus.23460

    CAS  Article  PubMed  Google Scholar 

  5. 5.

    Horga A, Rayan DLR, Matthews E, Sud R, Fialho D, Durran SCM et al (2013) Prevalence study of genetically defined skeletal muscle channelopathies in England. Neurology 80:1472–1475. https://doi.org/10.1212/WNL.0b013e31828cf8d0

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  6. 6.

    Cannon SC (2015) Channelopathies of skeletal muscle excitability. Compr Physiol 5:761–790. https://doi.org/10.1002/cphy.c140062

    Article  PubMed  PubMed Central  Google Scholar 

  7. 7.

    Wang Q, Zhao Z, Shen H, Bing Q, Li N, Hu J (2021) The clinical and genetic heterogeneity analysis of five families with primary periodic paralysis. Channels (Austin) 15:20–30. https://doi.org/10.1080/19336950.2020.1857980

    Article  Google Scholar 

  8. 8.

    Holm-Yildiz S, Witting N, Dahlqvist J, de Stricker BJ, Solheim T, Fornander F et al (2020) Permanent muscle weakness in hypokalemic periodic paralysis. Neurology 95:342–352. https://doi.org/10.1212/WNL.0000000000009828

    CAS  Article  Google Scholar 

  9. 9.

    Li F-F, Li Q-Q, Tan Z-X, Zhang S-Y, Liu J, Zhao E-y et al (2012) A novel mutation in CACNA1S gene associated with hypokalemic periodic paralysis which has a gender difference in the penetrance. J Mol Neurosci 46:378–383. https://doi.org/10.1007/s12031-011-9596-1

    CAS  Article  PubMed  Google Scholar 

  10. 10.

    Venance SL, Cannon SC, Fialho D, Fontaine B, Hanna MG, Ptacek LJ et al (2006) The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain 129:8–17. https://doi.org/10.1093/brain/awh639

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    Jurkat-Rott K, Lehmann-Horn F (2004) Periodic paralysis mutation MiRP2-R83H in controls: interpretations and general recommendation. Neurology 62:1012–1015. https://doi.org/10.1212/01.wnl.0000119392.29624.88

    Article  PubMed  Google Scholar 

  12. 12.

    Ryan DP, Dias da Silva MR, Soong TW, Fontaine F, Donaldson MR, Kung AWC et al (2010) Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis. Cell 140:88–98. https://doi.org/10.1016/j.cell.2009.12.024

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  13. 13.

    Marchant CL, Ellis FR, Halsall PJ, Hopkins PM, Robinson RL (2004) Mutation analysis of two patients with hypokalemic periodic paralysis and suspected malignant hyperthermia. Muscle Nerve 30:114–117. https://doi.org/10.1002/mus.20068

    Article  PubMed  Google Scholar 

  14. 14.

    Zhou H, Lillis S, Loy RE, Ghassemi F, Rose MR, Norwood F et al (2010) Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord 20:166–173. https://doi.org/10.1016/j.nmd.2009.12.005

    Article  PubMed  PubMed Central  Google Scholar 

  15. 15.

    Luo S, Xu M, Sun J, Qiao K, Song J, Cai S et al (2019) Identification of gene mutations in patients with primary periodic paralysis using targeted next-generation sequencing. BMC Neurol 19:92. https://doi.org/10.1186/s12883-019-1322-6

    Article  PubMed  PubMed Central  Google Scholar 

  16. 16.

    Groome JR, Lehmann-Horn F, Fan C, Wolf M, Winston V, Merlini L, Jurkat-Rott K (2014) NaV1.4 mutations cause hypokalaemic periodic paralysis by disrupting IIIS4 movement during recovery. Brain 137:998–1008. https://doi.org/10.1093/brain/awu015

    Article  PubMed  PubMed Central  Google Scholar 

  17. 17.

    Jurkat-Rott K, Mitrovic N, Hang C, Kouzmekine A, Iaizzo P, Herzog J et al (2000) Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc Natl Acad Sci USA 97:9549–9554. https://doi.org/10.1073/pnas.97.17.9549

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  18. 18.

    Wang Q, Liu M, Xu C, Tang Z, Liao Y, Du R et al (2005) Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a Chinese family. J Mol Med 83:203–208. https://doi.org/10.1007/s00109-005-0638-4

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    Lin SH, Hsu YD, Cheng NL, Kao MC (2005) Skeletal muscle dihydropyridine-sensitive calcium channel (CACNA1S) gene mutations in chinese patients with hypokalemic periodic paralysis. Am J Med 329:66–70. https://doi.org/10.1097/00000441-200502000-00003

    Article  Google Scholar 

  20. 20.

    Chabrier S, Monnier N, Lunardi J (2008) Early onset of hypokalaemic periodic paralysis caused by a novel mutation of the CACNA1S gene. J Med Genet 45:686–688. https://doi.org/10.1136/jmg.2008.059766

    CAS  Article  PubMed  Google Scholar 

  21. 21.

    Matthews E, Labrum R, Sweeney MG, Sud R, Haworth A, Chinnery PF et al (2009) Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. Neurology 72:1544–1547. https://doi.org/10.1212/01.wnl.0000342387.65477.46

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  22. 22.

    Ke T, Gomez CR, Mateus HE, Castano JA, Wang QK (2009) Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a South American Family. J Hum Genet 54:660–664. https://doi.org/10.1038/jhg.2009.92

    CAS  Article  PubMed  Google Scholar 

  23. 23.

    Hirano M, Kokunai Y, Nagai A, Nakamura Y, Saigoh K, Kusunoki S et al (2011) A novel mutation in the calcium channel gene in a family with hypokalemic periodic paralysis. J Neurol Sci 309:9–11. https://doi.org/10.1016/j.jns.2011.07.046

    CAS  Article  PubMed  Google Scholar 

  24. 24.

    Yang B, Yang Y, Tu W, Shen Y, Dong Q (2014) A rare case of unilateral adrenal hyperplasia accompanied by hypokalaemic periodic paralysis caused by a novel dominant mutation in CACNA1S: features and prognosis after adrenalectomy. BMC Urol 14:96. https://doi.org/10.1186/1471-2490-14-96

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  25. 25.

    Kurokawa M, Torio M, Ohkubo K, Tocan V, Ohyama N, Toda N et al (2020) The expanding phenotype of hypokalemic periodic paralysis in a Japanese family with p.Val876Glu mutation in CACNA1S. Mol Genet Genomic Med 8:e1175. https://doi.org/10.1002/mgg3.1175

    Article  PubMed  PubMed Central  Google Scholar 

  26. 26.

    Fan C, Lehmann-Horn F, Weber M-A, Bednarz M, Groome JR, Jonsson MKB, Jurkat-Rott K (2013) Transient compartment-like syndrome and normokalaemic periodic paralysis due to a Ca(v)1.1 mutation. Brain 136:3775–3786. https://doi.org/10.1093/brain/awt300

    Article  PubMed  PubMed Central  Google Scholar 

  27. 27.

    Yang H, Zhang H, Xing X (2013) V876E mutation in CACNA1S gene associated with severe hypokalemic periodic paralysis in a Chinese woman. J Formos Med Assoc 114(4):377–378. https://doi.org/10.1016/j.jfma.2013.07.007

    CAS  Article  PubMed  Google Scholar 

  28. 28.

    Carpenter D, Ringrose C, Leo V, Morris A, Robinson RL, Halsall PJ et al (2009) The role of CACNA1S in predisposition to malignant hyperthermia. BMC Med Genet 10:104. https://doi.org/10.1186/1471-2350-10-104

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  29. 29.

    Stewart SL, Hogan K, Rosenberg H, Fletcher JE (2001) Identification of the Arg1086His mutation in the alpha subunit of the voltage-dependent calcium channel (CACNA1S) in a North American family with malignant hyperthermia. Clin Genet 59:178–184. https://doi.org/10.1034/j.1399-0004.2001.590306.x

    CAS  Article  PubMed  Google Scholar 

  30. 30.

    Sugiura Y, Aoki T, Sugiyama Y, Hida C, Ogata M, Yamamoto T (2000) Temperature-sensitive sodium channelopathy with heat-induced myotonia and cold-induced paralysis. Neurology 54:179–181. https://doi.org/10.1212/wnl.54.11.2179

    Article  Google Scholar 

  31. 31.

    Sternberg D, Maisonobe T, Jurkat-Rott K, Nicole S, Launay E, Chauveau D et al (2001) Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A. Brain 124(1091–1099):10. https://doi.org/10.1093/brain/124.6.1091

    Article  Google Scholar 

  32. 32.

    Carle T, Lhuillier L, Luce S, Sternberg D, Devuyst O, Fontaine B, Tabti N (2006) Gating defects of a novel Na+ channel mutant causing hypokalemic periodic paralysis. Biochem Biophys Res Commun 348:653–661. https://doi.org/10.1016/j.bbrc.2006.07.101

    CAS  Article  PubMed  Google Scholar 

  33. 33.

    Guo M, Zhang X, Ma S, Xu T, Peng Y (2018) Screening of genetic mutations in a Chinese pedigree affected with hypokalemic periodic paralysis. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 35:74–77. https://doi.org/10.3760/cma.j.issn.1003-9406.2018.01.016

    Article  PubMed  Google Scholar 

  34. 34.

    Li HY, Zhou XL, Guo JF, Tang BS, Fu YJ, Sun JY (2020) A novel mutation of SCN4A gene causes hypokalemic periodic paralysis in a Chinese family. Zhonghua Yi Xue Za Zhi 100:3622–3625. https://doi.org/10.3760/cma.j.cn112137-20200421-01265

    CAS  Article  PubMed  Google Scholar 

  35. 35.

    Brugnoni R, Maggi L, Canioni E, Verde F, Gallone A, Ariatti A et al (2021) Next-generation sequencing application to investigate skeletal muscle channelopathies in a large cohort of Italian patients. Neuromuscul Disord 31:336–347. https://doi.org/10.1016/j.nmd.2020.12.003

    Article  PubMed  Google Scholar 

  36. 36.

    Vicart S, Sternberg D, Fontaine B, Meola G (2005) Human skeletal muscle sodium channelopathies. Neurol Sci 26:194–202. https://doi.org/10.1007/s10072-005-0461-x

    CAS  Article  PubMed  Google Scholar 

Download references

Funding

This work was supported by the Italian Ministry of Health [annual research funding, years 2018–2020].

Author information

Affiliations

Authors

Corresponding author

Correspondence to Raffaella Brugnoni.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 15 KB)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Brugnoni, R., Canioni, E., Filosto, M. et al. Mutations associated with hypokalemic periodic paralysis: from hotspot regions to complete analysis of CACNA1S and SCN4A genes. Neurogenetics (2021). https://doi.org/10.1007/s10048-021-00673-2

Download citation

Keywords

  • Hypokalemic periodic paralysis
  • CACNA1S and SCN4A genes
  • Sanger method
  • Next-generation sequencing